{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:06:07Z","timestamp":1781085967601,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajem.2022.01.058","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:50:46Z","timestamp":1643737846000},"page":"232.e1-232.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oseltamivir induced oral-only erythema multiforme"],"prefix":"10.1016","volume":"55","author":[{"given":"Steven","family":"Siemieniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2022.01.058_bb0005","series-title":"StatPearls","article-title":"Erythema multiforme","author":"Hafsi","year":"2021"},{"issue":"19","key":"10.1016\/j.ajem.2022.01.058_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015553","article-title":"Oseltamivir induced Stevens-Johnson syndrome\/toxic epidermal necrolysis-case report","volume":"98","author":"Zuo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajem.2022.01.058_bb0015","series-title":"UpToDate","article-title":"Erythema multiforme: Management","author":"Wetter","year":"2021"},{"issue":"2","key":"10.1016\/j.ajem.2022.01.058_bb0020","first-page":"82","article-title":"Erythema multiforme: recognition and management","volume":"100","author":"Trayes","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajem.2022.01.058_bb0025","series-title":"StatPearls","article-title":"Oseltamivir","author":"Sur","year":"2021"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2022.01.058_bb0030","first-page":"ii5","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ajem.2022.01.058_bb0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US oral neuraminidase study group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"issue":"571","key":"10.1016\/j.ajem.2022.01.058_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3399\/bjgp10X483292","article-title":"Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu)","volume":"60","author":"Smith","year":"2010","journal-title":"Br J Gen Pract"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:01:15Z","timestamp":1760025675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":8,"alternative-id":["S0735675722000614"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.01.058","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oseltamivir induced oral-only erythema multiforme","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.01.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}